199 related articles for article (PubMed ID: 16093206)
21. Formulation of microemulsion systems for transdermal delivery of aceclofenac.
Lee J; Lee Y; Kim J; Yoon M; Choi YW
Arch Pharm Res; 2005 Sep; 28(9):1097-102. PubMed ID: 16212244
[TBL] [Abstract][Full Text] [Related]
22. Development, characterization and evaluation of ginger extract loaded microemulsion: In vitro and Ex vivo release studies.
Akram A; Akhtar N; Waqas MK; Rasul A; Rehman KU; Khan J; Iqbal M; Khan BA
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1873-1877. PubMed ID: 31680086
[TBL] [Abstract][Full Text] [Related]
23. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery.
Cao M; Ren L; Chen G
AAPS PharmSciTech; 2017 Aug; 18(6):1960-1971. PubMed ID: 27914040
[TBL] [Abstract][Full Text] [Related]
24. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
[TBL] [Abstract][Full Text] [Related]
25. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo.
Sintov AC; Shapiro L
J Control Release; 2004 Mar; 95(2):173-83. PubMed ID: 14980766
[TBL] [Abstract][Full Text] [Related]
26. Influence of polymers on the bioavailability of microencapsulated celecoxib.
Homar M; Ubrich N; El Ghazouani F; Kristl J; Kerc J; Maincent P
J Microencapsul; 2007 Nov; 24(7):621-33. PubMed ID: 17763056
[TBL] [Abstract][Full Text] [Related]
27. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation.
Thakkar PJ; Madan P; Lin S
Pharm Dev Technol; 2014 May; 19(3):373-84. PubMed ID: 23634780
[TBL] [Abstract][Full Text] [Related]
28. [Water in oil microemulsions for transdermal delivery of fluorouracil].
Liu F; Xiao YY; Ping QN; Yang C
Yao Xue Xue Bao; 2009 May; 44(5):540-7. PubMed ID: 19618733
[TBL] [Abstract][Full Text] [Related]
29. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Wilgus TA; Ross MS; Parrett ML; Oberyszyn TM
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):367-84. PubMed ID: 11060900
[TBL] [Abstract][Full Text] [Related]
30. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
[TBL] [Abstract][Full Text] [Related]
31. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system.
Tsai YH; Lee KF; Huang YB; Huang CT; Wu PC
Int J Pharm; 2010 Mar; 388(1-2):257-62. PubMed ID: 20060453
[TBL] [Abstract][Full Text] [Related]
32. Transdermal delivery of curcumin via microemulsion.
Sintov AC
Int J Pharm; 2015 Mar; 481(1-2):97-103. PubMed ID: 25655717
[TBL] [Abstract][Full Text] [Related]
33. [Microemulsion-based gel of fluorouracil for transdermal delivery].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
[TBL] [Abstract][Full Text] [Related]
34. Preparation of high solubilizable microemulsion of naproxen and its solubilization mechanism.
Tian Q; Ren F; Xu Z; Xie Y; Zhang S
Int J Pharm; 2012 Apr; 426(1-2):202-210. PubMed ID: 22274589
[TBL] [Abstract][Full Text] [Related]
35. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
[TBL] [Abstract][Full Text] [Related]
36. Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib.
Tamilvanan S; Baskar R
Pharm Dev Technol; 2013; 18(4):761-71. PubMed ID: 23668371
[TBL] [Abstract][Full Text] [Related]
37. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.
Shamsher AA; Charoo NA; Rahman Z; Pillai KK; Kohli K
Pharm Dev Technol; 2014 Feb; 19(1):21-30. PubMed ID: 23281713
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations.
Ustündağ Okur N; Apaydın S; Karabay Yavaşoğlu NÜ; Yavaşoğlu A; Karasulu HY
Int J Pharm; 2011 Sep; 416(1):136-44. PubMed ID: 21723930
[TBL] [Abstract][Full Text] [Related]
39. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery.
Jain SK; Gupta Y; Jain A; Bhola M
Drug Deliv; 2007 Aug; 14(6):327-35. PubMed ID: 17701522
[TBL] [Abstract][Full Text] [Related]
40. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.
Estracanholli EA; Praça FS; Cintra AB; Pierre MB; Lara MG
AAPS PharmSciTech; 2014 Dec; 15(6):1468-75. PubMed ID: 24980082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
